The involvement of astrocytes and kynurenine pathway in Alzheimer's disease

被引：40
作者：
Ting, Ka Ka [1 ,3 ]
Brew, Bruce [2 ]
Guillemin, Gilles [1 ,3 ]
机构：
[1] St Vincents Hosp, Ctr Immunol, Sydney, NSW 2010, Australia
[2] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia
[3] Univ New S Wales, Dept Pharmacol, Sydney, NSW 2052, Australia
来源：
NEUROTOXICITY RESEARCH | 2007年 / 12卷 / 04期
基金：
英国医学研究理事会;
关键词：
astrocyte; kynurenine pathway; Alzheimer's disease; neuroinflammation;
D O I：
10.1007/BF03033908
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The kynurenine pathway (KP) and several of its neuroactive products, especially quinolinic acid (QUIN), are considered to be involved in the neuropathogenesis of Alzheimer's disease (AD). There is growing evidence suggesting that astrocytes play a critical role in the regulation of the excitotoxicity and inflammatory processes that occur during the evolution of AD. This review focuses on the role of astrocytes through their relation with the KP to the different features associated with AD including cytokine, chemokine and, adhesion molecule production, cytoskeletal changes, astrogliosis, excitotoxicity, apoptosis and neurodegeneration.
引用
收藏
页码：247 / 262
页数：16
相关论文
共 50 条
  • [31] Astrocytes in depression and Alzheimer's disease
    Liao, Yang
    Xing, Qu
    Li, Qianqian
    Zhang, Jing
    Pan, Ruiyuan
    Yuan, Zengqiang
    FRONTIERS OF MEDICINE, 2021, 15 (06) : 829 - 841
  • [32] Astrocytes in depression and Alzheimer’s disease
    Yang Liao
    Qu Xing
    Qianqian Li
    Jing Zhang
    Ruiyuan Pan
    Zengqiang Yuan
    Frontiers of Medicine, 2021, 15 : 829 - 841
  • [33] Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimer's Disease
    Li, Chuanyu
    Zhao, Rui
    Gao, Kai
    Wei, Zheng
    Yin, Michael Yaoyao
    Lau, Lok Ting
    Chui, Dehua
    Yu, Albert Cheung Hoi
    CURRENT ALZHEIMER RESEARCH, 2011, 8 (01) : 67 - 80
  • [34] Prevention and Treatment Strategies for Alzheimer's Disease: Focusing on Microglia and Astrocytes in Neuroinflammation
    Zhang, Shenghao
    Gao, Zhejianyi
    Feng, Lina
    Li, Mingquan
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 7235 - 7259
  • [35] Inflammation, negative affect, and amyloid burden in Alzheimer's disease: Insights from the kynurenine pathway
    Willette, Auriel A.
    Pappas, Colleen
    Hoth, Nathan
    Wang, Qian
    Klinedinst, Brandon
    Willette, Sara A.
    Larsen, Brittany
    Pollpeter, Amy
    Li, Tianqi
    Le, Scott
    Collazo-Martinez, Ana D.
    Mochel, Jonathan P.
    Allenspach, Karin
    Dantzer, Robert
    BRAIN BEHAVIOR AND IMMUNITY, 2021, 95 : 216 - 225
  • [36] Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau
    Jacobs, Kelly R.
    Lim, Chai K.
    Blennow, Kaj
    Zetterberg, Henrik
    Chatterjee, Pratishtha
    Martins, Ralph N.
    Brew, Bruce J.
    Guillemin, Gilles J.
    Lovejoy, David B.
    NEUROBIOLOGY OF AGING, 2019, 80 : 11 - 20
  • [37] Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
    Krishnamurthy, Shivani
    Gilot, David
    Ahn, Seong Beom
    Lam, Vincent
    Shin, Joo-Shik
    Guillemin, Gilles Jackie
    Heng, Benjamin
    CANCERS, 2021, 13 (20)
  • [38] Kynurenine and its metabolites in Alzheimer's disease patients
    Gulaj, E.
    Pawlak, K.
    Bien, B.
    Pawlak, D.
    ADVANCES IN MEDICAL SCIENCES, 2010, 55 (02): : 204 - 211
  • [39] Involvement of inflammasomes in the pathogenesis of Alzheimer's disease
    Beder, Narimene
    Belkhelfa, Mourad
    Leklou, Hakim
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 102 (01) : 11 - 29
  • [40] Cholesterol Dysmetabolism in Alzheimer's Disease: A Starring Role for Astrocytes?
    Staurenghi, Erica
    Giannelli, Serena
    Testa, Gabriella
    Sottero, Barbara
    Leonarduzzi, Gabriella
    Gamba, Paola
    ANTIOXIDANTS, 2021, 10 (12)
12345